MTOR and melanoma: However, analysis of A375 melanoma cells after treatment with palbociclib revealed significant downregulation of MYC target genes, and no change in mTOR signalling or c-MYC protein, suggesting that the mechanism in melanoma cells is distinct from colorectal cancer cells.